T2* Magnetic Resonance and Myocardial Iron in Thalassemia
- 1 November 2005
- journal article
- research article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1054 (1) , 373-378
- https://doi.org/10.1196/annals.1345.045
Abstract
Magnetic resonance T2* values of the myocardium are directly related to tissue iron levels. Minor effects from myocardial oxygenation and fibrosis are overwhelmed by the highly dominant iron effect in clinically relevant levels of myocardial iron overload. Myocardial T2* values less than 20 ms indicate iron overload, and this is considered severe when T2* is less than 10 ms. Decreasing myocardial T2* levels are associated with systolic and diastolic ventricular dysfunction. Most recorded cases of heart failure in thalassemia to date have occurred in patients with very low T2* values (in the severe range). Exceptions to this have occurred in patients with other causes of heart failure such as concomitant congenital heart disease. In patients presenting with heart failure who undergo aggressive chelation with continuous intravenous deferoxamine, longitudinal studies show that myocardial T2* increases, and this is accompanied by increases in ejection fraction and relief of heart failure. In cross-sectional studies, the myocardial T2* and ejection fraction of patients on deferiprone was superior to that of patients on deferoxamine. Randomized controlled prospective trials comparing these two drugs for their action in clearing myocardial iron, as measured by myocardial T2*, are under way and should report in 2005/2006. These trials will clarify the role of different chelators in the management of myocardial iron overload and may be valuable in reducing the toll of death in thalassemia from heart failure.Keywords
This publication has 16 references indexed in Scilit:
- Improved R2* measurements in myocardial iron overloadJournal of Magnetic Resonance Imaging, 2005
- Intercentre Reproducibility of Magnetic Resonance T2* Measurements of Myocardial Iron in ThalassaemiaThe International Journal of Cardiovascular Imaging, 2005
- Left ventricular diastolic function compared with T2* cardiovascular magnetic resonance for early detection of myocardial iron overload in thalassemia majorJournal of Magnetic Resonance Imaging, 2005
- Myocardial biopsy and T2* magnetic resonance in heart failure due to thalassaemiaBritish Journal of Haematology, 2004
- Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonanceBritish Journal of Haematology, 2004
- Myocardial iron loading in transfusion-dependent thalassemia and sickle cell diseaseBlood, 2004
- Interscanner reproducibility of cardiovascular magnetic resonance T2* measurements of tissue iron in thalassemiaJournal of Magnetic Resonance Imaging, 2003
- Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron poolBlood, 2003
- Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overloadEuropean Heart Journal, 2001
- Indirect evidence for the potential ability of magnetic resonance imaging to evaluate the myocardial iron content in patients with transfusional iron overloadMagnetic Resonance Materials in Physics, Biology and Medicine, 2001